{"id":266291,"date":"2026-09-24T10:25:55","date_gmt":"2026-09-24T04:55:55","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=266291"},"modified":"2026-09-24T10:25:55","modified_gmt":"2026-09-24T04:55:55","slug":"bal-pharma-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bal-pharma-best-stock-in-its-sector\/","title":{"rendered":"Is Bal Pharma the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Bal Pharma CMP Rs 108 (24 Sep 2026). Market cap Rs 172 Cr. ROE 7.64%. P\/E 23.72x versus Industry P\/E 38.33x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Bal Pharma is one of the names investors compare when screening the Healthcare sector, built on a 7.64% return on equity and a P\/E of 23.72x against an Industry P\/E of 38.33x. Whether Bal Pharma is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Bal Pharma<\/a> the best stock in its sector? The stock trades on the NSE at Rs 108 as of 24 September 2026, within its 52-week range of Rs 60.00 to Rs 124.60. Bal Pharma Ltd manufactures generic pharmaceutical formulations for domestic and export markets.<\/p>\n

Bal Pharma sits in the Healthcare sector, and its 7.64% ROE and 23.72x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n